| ?? |
?? ?? |
CAS |
MF |
 |
WH-4-023 (SRC inhibitor) |
|
|
|
|
TG101348 (JAK inhibitor) |
|
|
|
|
PFI-3 (EPIGENETIC READER DOMAIN inhibitor) |
|
|
|
|
PD184352 (MEK inhibitor) |
|
|
|
|
ML324 (HISTONE DEMETHYLASE inhibitor) |
|
|
|
|
KU0063794 (MTOR inhibitor) |
|
|
|
|
JNJ-7777120 (HISTAMINE RECEPTOR antagonist) |
|
|
|
|
GSK1292263 (GPR agonist) |
|
|
|
|
BYL719 (PI3K inhibitor) |
|
|
|
|
BML-210 (HDAC inhibitor) |
|
|
![2H-Pyran-4-propanamide, α-[4-(cyclopropylsulfonyl)phenyl]-N-(5-fluoro-2-thiazolyl)tetrahydro-, (αR)-](/CAS/20211123/GIF/745051-61-0.gif) |
2H-Pyran-4-propanamide, α-[4-(cyclopropylsulfonyl)phenyl]-N-(5-fluoro-2-thiazolyl)tetrahydro-, (αR)- |
745051-61-0 |
C20H23FN2O4S2 |
|
|
VENETOCLAX (ABT-199, GDC-0199) (BCL-2 inhibitor) |
|
|
|
|
U-104 (CARBONIC ANHYDRASE INHIBITOR) |
|
|
|
|
SALUBRINAL (PERK inhibitor) |
|
|
|
|
FLAVOPIRIDOL HCL (CDK inhibitor) |
|
|
|
|
DEFACTINIB (FAK inhibitor) |
|
|
|
|
CEDIRANIB (VEGFR inhibitor) |
|
|
|
|
BAY11-7082 (IΚB/IKK inhibitor) |
|
|
|
|
(-)-BLEBBISTATIN (ATPASE inhibitor) |
|
|
|
|
AG14361 (PARP1 inhibitor) |
|
|
|
|
ACP-196 (BTK inhibitor) |
|
|
|
|
ABT-737 (BCL-2 inhibitor) |
|
|
 |
CK-2127107 |
1345410-31-2 |
C19H18F2N6O |
|
|
VILAZODONE (SSRI inhibitor) |
|
|
|
|
TBA-354 (anti-tuberculosis) |
|
|
|
|
SAG (HEDGEHOG/SMOOTHENED agonist) |
|
|
|
|
PACLITAXEL (MICROTUBULE ASSOSIATED inhibitor) |
|
|
|
|
OSU-03012 (PDK-1 inhibitor) |
|
|
|
|
MONOMETHYL AURISTATIN E (microtubule-associated inhibitor) |
|
|
|
|
ML141 (RHO inhibitor) |
|
|
|
|
KN-93 PHOSPHATE (CAMK Inhibitor) |
|
|
|
|
GSK126 (EZH2 inhibitor) |
|
|
|
|
GELDANAMYCIN (HSP90 inhibitor) |
|
|
|
|
GANT61 (HEDGEHOG/SMOOTHENED Inhibitor) |
|
|
|
|
EPZ-6438 (E7438) (EZH2 inhibitor) |
|
|
|
|
EMPAGLIFLOZIN (SGLT inhibitor) |
|
|
|
|
DOXORUBICIN (TOPOISOMERASE inhibitor) |
|
|
|
|
DAPT (Γ-SECRETASE inhibitor) |
|
|
|
|
DACLATASVIR (HCV NS5A inhibitor) |
|
|
|
|
COMBRETASTATIN A4 (MICROTUBULE ASSOCIATED inhibitor) |
|
|
|
|
CABOZANTINIB (VEGFR inhibitor) |
|
|
|
|
BREFELDIN A (protein transport inhibitor) |
|
|
|
|
BKM120 (PI3K inhibitor) |
|
|
|
|
AKT INHIBITOR VIII (AKT inhibitor) |
|
|
|
|
ABT-199 (BCL-2 inhibitor) |
|
|
 |
??????? |
801-52-5 |
C16H20N4O5 |
|
|
VINCRISTINE (MICROTUBULE ASSOSIATED inhibitor) |
|
|
|
|
TETRABENAZINE (VMAT-2 Inhibitor) |
|
|
|
|
SNX-2112 (PF-04928473) (HSP90 antimony inhibitor) |
|
|
|
|
PLX4032 (RAF inhibitor) |
|
|
|
|
PD123319 (RAAS inhibitor) |
|
|
|
|
NS-2028 (SGC inhibitor) |
|
|
|
|
NECROSTATIN-1 (TNF-ALPHA inhibitor) |
|
|
|
|
ML323 (DUB inhibitor) |
|
|
|
|
KU-55933 (ATM inhibitor) |
|
|
|
|
(+)-JQ1 (BRD4 inhibitor) |
|
|
|
|
GSK2141795 (AKT inhibitor) |
|
|
|
|
GANETESPIB (HSP inhibitor) |
|
|
|
|
ENZALUTAMIDE (MDV3100) (AR inhibitor) |
|
|
|
|
BRIVANIB (VEGFR inhibitor) |
|
|
|
|
BARDOXOLONE METHYL (IΚB/IKK inhibitor) |
|
|
|
|
AZ20 (ATM/ATR inhibitor) |
|
|
|
|
ARN-509 (ANDROGEN RECEPTOR Inhibitor) |
|
|
 |
5-PREGNEN-3BETA-OL-20-ONE-16ALPHA-????? |
1434-54-4 |
C22H31NO2 |
|
|
TWS119 (GSK-3 inhibitor) |
|
|
|
|
SC-514 (IΚB/IKK inhibitor) |
|
|
|
|
ROMIDEPSIN (HDAC inhibitor) |
|
|
|
|
REGADENOSON (ADENOSINE RECEPTOR agonist) |
|
|
|
|
PYRIDONE 6 (JAK inhibitor) |
|
|
|
|
PRT062607 HCL (SYK inhibitor) |
|
|
|
|
PAZOPANIB (VEGFR inhibitor) |
|
|
|
|
MLN9708 (20S PROTEASOME Inhibitor) |
|
|
|
|
INDIPLON (GABA RECEPTOR Conditioner) |
|
|
|
|
FIDAXOMICIN (DNA/RNA SYNTHESIS Inhibitor) |
|
|
|
|
EVEROLIMUS (MTOR inhibitor) |
|
|
|
|
ENTOSPLETINIB (SYK inhibitor) |
|
|
|
|
DABRAFENIB (RAF inhibitor) |
|
|
|
|
CYT997 (LEXIBULIN) (MICROTUBULES inhibitor) |
|
|
|
|
BMS-5 (LIMK inhibitor) |
|
|
|
|
AZD7762 (CHK inhibitor) |
|
|
|
|
AG1024 (IGF-1R inhibitor) |
|
|
|
|
VISMODEGIB (HEDGEHOG/SMOOTHENED INHIBITOR) |
|
|
|
|
REMODELIN (HISTONE ACETYLTRANSFERASE inhibitor) |
|
|
|
|
PAC-1 (CASPASE Activator) |
|
|
|
|
OSELTAMIVIR PHOSPHATE (NEURAMINIDASE Inhibitor) |
|
|
|
|
MONENSIN (protein transport inhibitor) |
|
|
|
|
LINIFANIB (VEGFR inhibitor) |
|
|
|
|
LCZ696 (RAAS inhibitor) |
|
|
|
|
IONOMYCIN (calcium ionophore) |
|
|
|
|
HYDROXYUREA (DNA SYNTHESIS inhibitor) |
|
|
|
|
GZD824 DIMESYLATE (BCR-ABL inhibitor) |
|
|
|
|
FORETINIB (C-MET inhibitor) |
|
|
|
|
DAPIVIRINE (REVERSE TRANSCRIPTASE Inhibitor) |
|
|
|
|
CNX-774 (BTK inhibitor) |
|
|
|
|
BIRB 796 (P38 MAPK Inhibitor) |
|
|
|
|
BAY87-2243 (HIF inhibitor) |
|
|
|
|
B-AP15 (DUB inhibitor) |
|
|
|
|
APIXABAN (FACTOR XA Inhibitor) |
|
|
|
|
TPA Deficient Plasma |
|
|
 |
??? |
9063-57-4 |
C21H40N8O6 |